Oncology. Recruiting the cell's own guardian for cancer therapy.
Marx
Jean
J
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000627:therapeutic use*; D017209:Apoptosis; D002986:Clinical Trials as Topic; D004354:Drug Screening Assays, Antitumor; D016158:Genes, p53; D005818:Genetic Engineering; D006801:Humans; D048288:Imidazolines / Q000627:therapeutic use; D051379:Mice; D009154:Mutation; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D051736:Proto-Oncogene Proteins c-mdm2 / Q000378:metabolism; D011743:Pyrimidines / Q000378:metabolism / Q000627:therapeutic use; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
D000970:Antineoplastic Agents; D048288:Imidazolines; D011743:Pyrimidines; D016159:Tumor Suppressor Protein p53; D051736:Proto-Oncogene Proteins c-mdm2; C402665:CP 31398